COVID-19 and Rheumatoid Arthritis share myeloid pathogenic and resolving pathways
L. MacDonald, T. D. Otto, A. Elmesmari, B. Tolusso, D. Somma, C. McSharry, E. Gremese, I. B. McInnes, S. Alivernini, M. Kurowska-Stolarska
This study identifies shared myeloid pathways between COVID-19 pneumonitis and RA synovitis, highlighting MerTK as a therapeutic target for both conditions.
bioRxiv · Jul 26, 2020 · PreprintImmunology